<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=SPR</id>
	<title>SPR - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=SPR"/>
	<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=SPR&amp;action=history"/>
	<updated>2026-10-18T03:27:28Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://eln.excellgen.com/index.php?title=SPR&amp;diff=18492&amp;oldid=prev</id>
		<title>Paul.xu: Created page with &quot;Surface plasmon resonance (SPR)&lt;br/&gt;For the immobilization onto CM5 chip, all antigens were&lt;br/&gt;activated via thiol labeling kit (GE Healthcare, Buckinghamshire,&lt;br/&gt;UK). A 0....&quot;</title>
		<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=SPR&amp;diff=18492&amp;oldid=prev"/>
		<updated>2018-06-28T19:03:35Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;Surface plasmon resonance (SPR)&amp;lt;br/&amp;gt;For the immobilization onto CM5 chip, all antigens were&amp;lt;br/&amp;gt;activated via thiol labeling kit (GE Healthcare, Buckinghamshire,&amp;lt;br/&amp;gt;UK). A 0....&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Surface plasmon resonance (SPR)&amp;lt;br/&amp;gt;For the immobilization onto CM5 chip, all antigens were&amp;lt;br/&amp;gt;activated via thiol labeling kit (GE Healthcare, Buckinghamshire,&amp;lt;br/&amp;gt;UK). A 0.5 mg of antigens in 0.5 mL were prepared in&amp;lt;br/&amp;gt;morpholinoethanesulfonic acid (MES) buffer. Then, 0.25 mL of&amp;lt;br/&amp;gt;2-(2-pyridinyldithio)ethaneamine (PDEA) (15 mg/mL) in 0.1 M&amp;lt;br/&amp;gt;MES buffer was added. After adding 25 mL of 0.4 M 1-ethyl-3-(3-&amp;lt;br/&amp;gt;dimethylaminopropyl)-carbodiimide (EDC), the mixtures were&amp;lt;br/&amp;gt;incubated at 25uC for 10 min. The buffers were exchanged to PBS&amp;lt;br/&amp;gt;via dialysis after the incubation. A Biacore 3000 (GE Healthcare)&amp;lt;br/&amp;gt;and CM5 chip (GE Healthcare) was used in all SPR analysis. SPR&amp;lt;br/&amp;gt;experiments were carried out at a flow rate of 10 mL/min using&amp;lt;br/&amp;gt;PBS as running buffer. For the activation of the surface of CM5&amp;lt;br/&amp;gt;chip, 0.2 M EDC and 0.5 M N-hydroxysuccinimide (NHS)&amp;lt;br/&amp;gt;solution was injected for 2 min. And 40 mM cystamine solution&amp;lt;br/&amp;gt;was injected for 3 min, and then, 0.1 M dithioerythritol (DTE) in&amp;lt;br/&amp;gt;0.1 sodium borate solution was injected for 3 min. After the&amp;lt;br/&amp;gt;activation of the chip surfaces, 100 mg/mL of activated antigens&amp;lt;br/&amp;gt;were injected for 7 min. For deactivation of excess reactive groups&amp;lt;br/&amp;gt;on the chip surface, 20 mM PDEA and 1 M NaCl solution in&amp;lt;br/&amp;gt;0.1 M sodium acetate was injected for 4 min. Finally, various&amp;lt;br/&amp;gt;concentrations of isolated scFvs were injected for 5 min and the&amp;lt;br/&amp;gt;binding signal was detected. The KD values of scFvs were&amp;lt;br/&amp;gt;evaluated by measuring Kon and Koff in BIA evaluation software&lt;br /&gt;
[[Category:Antibodies]]&lt;/div&gt;</summary>
		<author><name>Paul.xu</name></author>
	</entry>
</feed>